González-del-Alba, A.
Arranz, J. Á.
Bellmunt, J.
Maroto, J. P.
Fernández-Calvo, O.
Valderrama, B. P.
González-Billalabeitia, E.
Méndez-Vidal, M. J.
Cassinello, J.
Romero-Laorden, N.
Climent, M. Á.
Puente, J.
Peláez, I.
Lázaro-Quintela, M.
Gallardo, E.
Suárez, C. http://orcid.org/0000-0002-0502-5528
Article History
Received: 21 January 2020
Accepted: 1 May 2020
First Online: 21 May 2020
Compliance with ethical standards
:
: A González del Alba declared honoraria from Astellas Pharma, Ipsen, Janssen-Cilag, Novartis, Pfizer, Roche and Sanofi, participated in advisory boards for Astellas Pharma, AstraZeneca, Bayer, Bristol-Myers Squibb, Eisai, EUSA Pharma, Ipsen, Janssen-Cilag, Novartis, Pfizer, Pierre Fabre, Roche and Sanofi, was compensated as speaker by Ipsen, Janssen-Cilag, Pfizer, Pierre Fabre and Roche, received research grants from Astellas Pharma, and benefitted from travel and accommodation expenses funded by Astellas Pharma, Bristol-Myers Squibb, Ipsen, Janssen-Cilag, Merck Sharp and Dohme, Pfizer, Roche and Sanofi. JA Arranz declared honoraria from Astellas Pharma, Bristol-Myers Squibb, EUSA Pharma, Janssen-Cilag and Novartis, participated in advisory boards for Astellas Pharma, Bayer, Bristol-Myers Squibb, EUSA Pharma, Janssen-Cilag, Ipsen, Merck Sharp and Dohme, Novartis and Pfizer, received research grants from Bristol-Myers Squibb, Novartis and Pierre Fabre, and benefitted from travel and accommodation expenses funded by Bristol-Myers Squibb, Janssen-Cilag, Merck Sharp & Dohme and Pfizer. J Bellmunt declared honoraria from Pfizer and Pierre Fabre, participated in advisory boards for AstraZeneca, Bayer, Bristol-Myers Squibb, Merck Sharp & Dohme, Merck, Pfizer, Roche and Sanofi, received research grants from Merck, Pfizer and Roche. JP Maroto participated in advisory boards for Astellas Pharma, AstraZeneca, Bayer, Janssen-Cilag, Ipsen, Novartis, Pfizer, Roche and Sanofi, and benefitted from travel and accommodation expenses funded by Ipsen, Pfizer and Roche. O Fernández-Calvo declared honoraria from Astellas Pharma, Eisai, Ipsen, Novartis, Pfizer, Roche and Sanofi, participated in advisory boards for Astellas Pharma, Pfizer and Sanofi, and benefitted from travel and accommodation expenses funded by Ipsen, Pfizer and Roche. B P Valderrama declared honoraria from Astellas Pharma, Bayer, Bristol-Myers Squibb, Ipsen, Novartis, Pierre Fabre and Roche, participated in advisory boards for Astellas Pharma, Bayer, Bristol-Myers Squibb, Ipsen, Merck Sharp & Dohme, Pierre Fabre, Roche and Sanofi, and benefitted from travel and accommodation expenses funded by Bristol-Myers Squibb, Janssen-Cilag and Pfizer. E González-Billalabeitia participated in advisory boards for AstraZeneca and was compensated as speaker or travel grants by Astellas Pharma, Bayer, Bristol-Myers Squibb, EUSA Pharma, Janssen-Cilag, Pfizer and Sanofi. MJ Méndez-Vidal declared honoraria from Astellas Pharma, Bayer, Bristol-Myers Squibb, Janssen-Cilag, Novartis, Pfizer, Roche and Sanofi, and benefitted from travel and accommodation expenses funded by Astellas Pharma, Bristol-Myers Squibb, Janssen-Cilag and Pfizer. J Cassinello declared honoraria from Astellas Pharma, AstraZeneca, Janssen-Cilag, Pfizer and Roche, participated in advisory boards for Novartis, Roche and Sanofi, received research grants from Astellas Pharma and Pfizer, and benefitted from travel and accommodation expenses funded by Bristol-Myers Squibb, Pfizer and Roche. N Romero Laorden declared honoraria from Astellas Pharma, Bayer, Janssen-Cilag, Pfizer, PharmaMar, Roche and Sanofi, received research grants from Astellas Pharma, Bayer, Janssen-Cilag and Sanofi, and benefitted from travel and accommodation expenses funded by Janssen-Cilag, Pfizer and Roche. MA Climent participated in advisory boards for Bristol-Myers Squibb, Ipsen, Janssen-Cilag, Merck Sharp & Dohme, Roche and Sanofi, was compensated as speaker by Bristol-Myers Squibb, Janssen-Cilag, Merck Sharp and Dohme, Novartis, Pfizer and Roche, and benefit from travel and accommodation expenses funded by Astellas Pharma, Ipsen, Janssen-Cilag, Merck Sharp and Dohme and Roche. J Puente declared honoraria from Astellas Pharma, AstraZeneca, Bayer, Bristol-Myers Squibb, Eisai, EUSA Pharma, Ipsen, Janssen-Cilag, Merck Sharp and Dohme, Pfizer, Pierre Fabre, Roche and Sanofi, participated in advisory boards for Astellas Pharma, Bayer, Bristol-Myers Squibb, Clovis, Eisai, Janssen-Cilag, Ipsen, Merck Sharp and Dohme, Pfizer, Roche and Sanofi, received research grants from Astellas Pharma and Pfizer, and benefitted from travel and accommodation expenses funded by Bristol-Myers Squibb, Janssen-Cilag, Merck Sharp and Dohme, Pfizer and Roche. I Peláez, Cabueñes declared honoraria from Astellas Pharma, AstraZeneca, Eisai, Novartis, Pfizer and Roche, participated in advisory boards for Pfizer, and benefitted from travel and accommodation expenses funded by Ipsen, Pfizer and Roche. M Lázaro-Quintela participated in advisory boards from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Esai, EUSA Pharma, Ipsen, Merck Sharp and Dohme and Roche, was compensated as speaker by AstraZeneca, Boehringer Ingelheim, Ipsen, Janssen-Cilag, Lilly, Merck Sharp and Dohme, Novartis and Roche, and benefitted from travel and accommodation expenses funded by AstraZeneca, Bristol-Myers Squibb, Lilly, Merck Sharp and Dohme, Pfizer and Roche. E Gallardo participated in advisory boards for Merck, Pfizer, Ipsen, Novartis, Eisai, EUSA Pharma, Bristol-Myers Squibb, Bayer, Roche, Sanofi, Janssen-Cilag, Astellas Pharma, Rovi, Daiichi Sankyo, Techdow, was compensated as speaker by Bayer, Ipsen, Pfizer, Bristol-Myers Squibb, Novartis, Eisai, Roche, Astellas, Janssen, Sanofi, Rovi, Daiichi Sankyo, Leo Pharma, Menarini, received research grants from Pfizer, Bayer, Ipsen, Roche, Bristol-Myers Squibb, Novartis, Merck Sharp and Dohme, Incyte, Aveo, Eisai, Calithera, Leo Pharma, Daiichi Sankyo, AstraZeneca, Sanofi, Astellas, Bavarian-Nordic, Clovis, Janssen, and benefitted from travel and accommodation expenses funded by Pfizer, Bayer, Ipsen, Roche, Novartis, Eisai, Bristol-Myers Squibb, Pierre Fabre, Astellas Pharma, Janssen-Cilag, Sanofi and Ferrer. C Suárez declared honoraria from Astellas Pharma, AstraZeneca, Bayer, Bristol-Myers Squibb, Eisai, Ipsen, Merck Sharp & Dohme, Novartis, Pfizer, Roche and Sanofi.
: The study has been performed in accordance with the ethical standards of the Declaration of Helsinki and its later amendments. This article does not contain any studies with human participants or animals performed by any of the authors.
: For this type of study formal consent is not required.
Free to read: This content has been made available to all.